Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen (Q46154968)
Jump to navigation
Jump to search
scientific article published in March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen |
scientific article published in March 2009 |
Statements
1 reference
Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen (English)
1 reference
Masatsugu Okishiro
1 reference
Tetsuya Taguchi
1 reference
Seung Jin Kim
1 reference
Kenzo Shimazu
1 reference
Yasuhiro Tamaki
1 reference
Shinzaburo Noguchi
1 reference
1 March 2009
1 reference
1 reference
115
1 reference
5
1 reference
952-961
1 reference
1 reference
Identifiers
1 reference
1 reference